Biodexa Pharmaceuticals PLC ADR (BDRX)
Market Closed
3 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 5900
+0.09
+2.57%
$
550.24K Market Cap
- P/E Ratio
- Div Yield
26,839 Volume
- Eps
$ 3.5
Previous Close 
Want to track BDRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore why
Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) opened more than 100% up on Tuesday after reporting encouraging Phase 2 data for eRapa.
Invezz | 2 years ago
Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore why
Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) opened more than 100% up on Tuesday after reporting encouraging Phase 2 data for eRapa.
Invezz | 2 years ago
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?
Biodexa Pharmaceuticals (NASDAQ: BDRX ) stock is rocketing higher on Tuesday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company's shares. This has more than 15.8 million shares of BDRX stock changing hands as of this writing.
Investorplace | 2 years ago
